SEC Form 4 · accession 0000899243-15-009323
APPLIED GENETIC TECHNOLOGIES CORP · AGTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Rosen
Director
Period of report
Nov 19, 2015
Accepted (ET)
Dec 4, 2015 · 4:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001273636
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $16.06 | Nov 19, 2015 | A | 6,200 | A | — | Nov 19, 2025 | Common Stock | 6,200 | 6,200 | D |
Explanation of responses
- F1Option becomes exercisable on November 19, 2016.